Related Experiment Video
Updated: Jan 22, 2026

Biotinylated Cell-penetrating Peptides to Study Intracellular Protein-protein Interactions
Published on: December 20, 2017
The cell-penetrating FOXM1 N-terminus (M1-138) demonstrates potent inhibitory effects on cancer cells by targeting
Zhenwang Zhang1, Huitong Bu1, Jingwei Yu1
1State Key Laboratory of Chemo/Biosensing and Chemometrics, College of Biology, Hunan Engineering Research Center for Anticancer Targeted Protein Pharmaceuticals, Hunan University, Changsha, Hunan 410082, China.
Abstract:
Transcription factor FOXM1 is involved in stimulating cell proliferation, enhancing DNA damage repair, promoting metastasis of cancer cells, and the inhibition of FOXM1 has been shown to prevent the initiation and progression of multiple cancers and FOXM1 is considered to be an effective target for tumor therapeutic drug development. The N-terminus of FOXM1 has been found to prevent transcriptional activities of FOXM1 and to mediate the interaction between FOXM1 and SMAD3.
Methods:
A recombinant FOXM1 N-terminal domain (1-138aa) fused with a nine arginine cell-penetrating peptide is produced with an E. coli expression system and named as M1-138. The effects of M1-138 on the proliferation, migration, and tumorigenic ability of cancer cells are analyzed in vitro with cell counting, transwell assays, and colony formation assays. Electrophoretic mobility shift assays (EMSAs) and Luciferase activity assays are used to test the DNA binding ability and transcriptional activity of transcription factors. The levels of mRNAs and proteins are measured by quantitative-PCR, Western blotting or Immunohistochemistry. The interactions among proteins are analyzed with Pull-down and Co-immunoprecipitation (Co-IP) assays. The nude mouse engrafted tumor models are used to test the inhibitory effects of M1-138 in vivo.
Results:
M1-138 diminishes the proliferation and migration abilities of cancer cells through binding to FOXM1 and FOXM1-interacting factor SMAD3, and consequently attenuating FOXM1 transcriptional activities from both direct and indirect FOXM1-promoter binding mechanisms and interfering with the interaction between FOXM1 and SMAD3. Treatment of M1-138 prevents tumorigenicity of cancer cells and inhibits tumor growth in nude mouse xenograft models with no obvious signs of toxicity.
Conclusion:
M1-138 is a promising drug candidate for the development of anti-cancer therapeutics targeting FOXM1 and SMAD3.
Insights
A novel compound, M1-138, effectively inhibits cancer cell proliferation and migration by targeting transcription factor FOXM1 and its interaction with SMAD3. This therapeutic strategy shows promise for developing new anti-cancer drugs.
Area of Science:
- Molecular Biology
- Cancer Research
- Drug Development
Background:
- Transcription factor FOXM1 is crucial for cell proliferation, DNA repair, and cancer metastasis.
- Inhibiting FOXM1 can prevent cancer initiation and progression, making it a key therapeutic target.
- The N-terminus of FOXM1 regulates its transcriptional activity and interaction with SMAD3.
Purpose of the Study:
- To investigate the anti-cancer effects of a novel recombinant FOXM1 N-terminal domain (1-138aa) fused with a cell-penetrating peptide, named M1-138.
- To analyze the impact of M1-138 on cancer cell proliferation, migration, and tumorigenicity.
- To elucidate the molecular mechanisms underlying M1-138's anti-cancer activity.
Main Methods:
- Production of M1-138 using an E. coli expression system.
- In vitro analysis of cancer cell proliferation, migration, and colony formation.
- Assays to evaluate DNA binding, transcriptional activity, protein interactions, and mRNA/protein levels.
- In vivo studies using nude mouse xenograft models.
Main Results:
- M1-138 significantly reduced cancer cell proliferation and migration.
- The compound attenuated FOXM1 transcriptional activity by interfering with FOXM1 and SMAD3 interaction.
- M1-138 inhibited tumor growth in vivo without observable toxicity.
Conclusions:
- M1-138 demonstrates potent anti-cancer properties by targeting FOXM1 and SMAD3.
- The compound effectively inhibits cancer cell proliferation, migration, and tumorigenicity.
- M1-138 represents a promising drug candidate for developing novel anti-cancer therapeutics.
Related Concept Videos
Excitatory and Inhibitory Effects of Neurotransmitters
Targeted Cancer Therapies
There are several types of targeted therapies against...
Molecular Factors Affecting Cell Division
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...
Biological Effects of Radiation
Target Cell Response to Hormones
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Factors Affecting Dissolution: Particle Size and Effective Surface Area

